An angiotensin II type 2 receptor (AT.sub.2 receptor), structurally related cell receptors, nucleic acids encoding such AT.sub.2 receptors, AT.sub.2 receptor-related peptides, and methods of using AT. sub.2 receptors and AT.sub.2 receptor-encoding nucleic acids are provide. AT. sub.2 receptor-specific binding compounds are disclosed including antibodies to AT.sub.2 receptor epitopes. The invention provides AT.sub.2 receptor-based pharmaceutical compositions and AT.sub.2 receptor-based methods rot screening chemical libraries for regulators of cell growth/differentiation. In particular, the invention provides methods for identifying agonists and antagonists of the disclosed AT.sub.2 receptor. Such compositions find broad utility in the treatment of cardiovascular disease, cancer, reproductive disease, etc.
展开▼